Summit Therapeutics Appoints Dr. Robert Booth, Renowned Executive and Scientific Leader, to its Board of Directors

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Dr. Robert Booth, PhD, has been appointed to its Board of

Related Keywords

Stanford University ,California ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Menlo Park ,Maky Zanganeh ,Robert Booth ,Robertw Duggan ,Dave Gancarz ,Twitter ,Stanford University School Of Medicine ,Summit Therapeutic Mission Statement ,Cymabay Inc ,Nasdaq ,Thryv Therapeutics Inc ,Summit Therapeutics Inc ,Curasen Therapeutics Inc ,Celera Genomics Inc ,Team Summit ,Drug Administration ,Healthcare Pharmaceuticals Industry ,Exchange Commission ,University Of London ,Celera Genomics ,Company Board ,Pharmacyclics Inc ,Virobay Inc ,Chief Executive Officer ,Adding Robert ,Stanford University School ,Curasen Therapeutics ,Executive Chairman ,Chief Scientific Officer ,Senior Vice President ,Hoffman La Roche ,Co Chief Executive Officer ,Urte Gayko ,Nasdaq Global Market ,Summit Investor Relations ,Stakeholder Relations ,Private Securities Litigation Reform Act ,Therapeutics Appoints ,Renowned Executive ,Scientific Leader ,Pharmaceuticals Industry ,Internet News Presswire ,Editorial Guidelines ,Summit ,Therapeutics ,Appoints ,Dr ,Robert ,Booth , ,Renowned ,Executive ,Hand ,Scientific ,Leader ,To ,Its ,Board ,Of ,Directors ,